EUS-guided in vivo microdialysis of the pancreas: a novel technique with potential diagnostic and therapeutic application

Delgado, 1972, Dialytrode for long term intracerebral perfusion in awake monkeys, Arch Int Pharmacodyn Ther, 198, 9 Müller, 2002, Science, medicine, and the future: Microdialysis, BMJ, 324, 588, 10.1136/bmj.324.7337.588 Lee, 2008, Microdialysis applications in neuroscience, Neurol Res, 30, 661, 10.1179/174313208X289570 Zhou, 2005, In vivo microdialysis for PK and PD studies of anticancer drugs, AAPS J, 7, E659, 10.1208/aapsj070366 Müller, 1997, 5-fluorouracil kinetics in the interstitial tumor space: clinical response in breast cancer patients, Cancer Res, 57, 2598 Mader, 2003, Penetration of capecitabine and its metabolites into malignant and healthy tissues of patients with advanced breast cancer, Br J Cancer, 88, 782, 10.1038/sj.bjc.6600809 Joukhadar, 2001, Penetration of dacarbazine and its active metabolite 5-aminoimidazole-4-carboxamide into cutaneous metastases of human malignant melanoma, Cancer, 92, 2190, 10.1002/1097-0142(20011015)92:8<2190::AID-CNCR1562>3.0.CO;2-2 Schmidt, 2008, Clinical microdialysis in skin and soft tissues: an update, J Clin. Pharmacol, 48, 351, 10.1177/0091270007312152 Kitano, 2000, Gastric submucosal microdialysis: a method to study gastrin- and food-evoked mobilization of ECL cell histamine in conscious rats, Regul Pept, 86, 113, 10.1016/S0167-0115(99)00096-8 Deeba, 2008, Use of rapid sampling microdialysis for intraoperative monitoring of bowel ischemia, Dis Colon Rec, 51, 1408, 10.1007/s10350-008-9375-4 Gan, 2007, Role of EUS, Gastrointest Endosc, 66, 425, 10.1016/j.gie.2007.05.026 Burris, 1997, Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial, J Clin Oncol, 15, 455, 10.1200/JCO.1997.15.6.2403 Ueno, 2005, A phase I study of combination chemotherapy with gemcitabine and oral S-1 for advanced pancreatic cancer, Oncology, 69, 421, 10.1159/000089997 Nakamura, 2006, Phase II trial of oral S-1 combined with gemcitabine in metastatic pancreatic cancer, Br J Cancer, 94, 1575, 10.1038/sj.bjc.6603168 Tatsumi, 1987, Inhibitory effects of pyrimidine, barbituric acid and pyrimidine derivatives on 5-fluorouracil degradation in rat liver extracts, Jpn J Cancer, 78, 748 Takechi, 2002, Enhancement of the antitumour activity of 5-fluorouracil (5-FU) by inhibiting dihydropyrimidine dehydrogenase activity (DPD) using 5-chloro-2,4-dihydroxypyrimidine (CDHP) in human tumour cells, Eur J Cancer, 38, 1271, 10.1016/S0959-8049(02)00048-5 Shirasaka, 1993, Inhibition by oxonic acid of gastrointestinal toxicity of 5-fluorouracil without loss of its antitumour activity in rats, Cancer Res, 53, 4004 Marunaka, 1982, Gas chromatographic-mass fragmentographic determination of 5-fluorouracil as a metabolic of new 5-fluorouracil derivatives, Chem Pharm Bull, 30, 1868, 10.1248/cpb.30.1868 Odagiri, 1988, Determination of 5-fluorouracil in plasma and liver after oral administration of 5′-deoxy-5-fluorouridine using gas chromatography-mass spectrometry, J Pharmacobiodyn, 11, 234, 10.1248/bpb1978.11.234 Nakagawa, 1993, Exocrine interstitial insulin and somatostatin in the perfused dog pancreas, Am J Physiol (Gastrointest Liver Physiol), 264 Meriläinen, 2008, Acute edematous and necrotic pancreatitis in a porcine model, Scand J Gastroenterol, 43, 1259, 10.1080/00365520802158580